Fundz

GeneDx Appoints Everett Cunningham as Chief Executive Officer

PUBLIC · WGSNov 18, 2026

Position

Chief Executive Officer

Company

GeneDx Holdings

Everett Cunningham
Stamford

Description

Everett Cunningham has been appointed as the Chief Executive Officer of GeneDx. He is set to lead the company into its next phase of growth, leveraging his extensive experience in diagnostics and commercial leadership.

Quick answer

GeneDx Appoints Everett Cunningham as Chief Executive Officer (November 18, 2026). GeneDx Holdings is based in Stamford, Connecticut, United States.

Who is the new Chief Executive Officer at GeneDx Holdings?
GeneDx Holdings named Everett Cunningham Chief Executive Officer, announced November 18, 2026.
What did GeneDx Holdings announce on November 18, 2026?
Everett Cunningham has been appointed as the Chief Executive Officer of GeneDx. He is set to lead the company into its next phase of growth, leveraging his extensive experience in diagnostics and commercial leadership.
What does GeneDx Holdings do?
GeneDx Holdings Corp. provides genomic testing services focused on diagnosing rare and inherited diseases.
Where is GeneDx Holdings based?
GeneDx Holdings is based in Stamford, Connecticut, United States.

Source: Fundz verified event record.

Who to call at GeneDx Holdings, and when

A new leader at GeneDx Holdings brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day GeneDx Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GeneDx Holdings, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GeneDx Holdings. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GeneDx Holdings

Location

333 Ludlow Street

Stamford, Connecticut, United States

About

GeneDx Holdings Corp. provides genomic testing services focused on diagnosing rare and inherited diseases. The company aims to enhance patient care through advanced genomic technologies. It is known for its commitment to accuracy and innovation in genomic testing.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GeneDx Holdings changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Melanie
Likely contact at this company
••••••••@••••••••

See Melanie's verified email →

Heidi
Likely contact at this company
••••••••@••••••••

See Heidi's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for GeneDx Holdings's next move

Learn about Strategic plan

GeneDx Holdings changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.